Real-time enrollment status for this relapsed/refractory small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 9:09 PM UTC
| NCT Number | NCT07325136 |
| Recruiting Status | Recruiting |
| Condition | Relapsed/Refractory Small Cell Lung Cancer |
| Phase | PHASE1 |
| Target Enrollment | 240 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 27, 2026: Clinical trial NCT07325136 is currently recruiting participants. This phase1 study for relapsed/refractory small cell lung cancer is actively seeking new participants at 5 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07325136 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07325136 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.